US FDA Approves Lupin’s Valbenazine Capsules
As the pharmaceutical giant received approval for valbenazine capsules from the US Food and Drug Administration (FDA), its shares soared by more than 5% on Friday. Adults with tardive dyskinesia, a medical condition that affects movement and facial tics like lip-smacking and grimacing, are treated with this medication. According to Lupin, the US FDA FDA […]
Continue Reading